Mutual of America Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.32M Sell
42,054
-640
-1% -$54.4K 0.03% 589
2026
Q1
$3.68M Sell
42,694
-3,672
-8% -$330K 0.04% 513
2025
Q4
$4.05M Sell
46,366
-5,649
-11% -$429K 0.04% 505
2025
Q3
$2.98M Sell
52,015
-4,156
-7% -$239K 0.03% 643
2025
Q2
$3.32M Sell
56,171
-2,367
-4% -$153K 0.04% 612
2025
Q1
$4.28M Sell
58,538
-1,542
-3% -$127K 0.05% 478
2024
Q4
$4.97M Sell
60,080
-980
-2% -$77.3K 0.05% 448
2024
Q3
$4.37M Sell
61,060
-3,425
-5% -$242K 0.05% 531
2024
Q2
$4.42M Sell
64,485
-4,251
-6% -$254K 0.05% 516
2024
Q1
$3.69M Sell
68,736
-2,585
-4% -$139K 0.04% 630
2023
Q4
$3.8M Sell
71,321
-4,982
-7% -$243K 0.04% 606
2023
Q3
$3.79M Buy
76,303
+18,244
+31% +$1.02M 0.05% 556
2023
Q2
$3.46M Sell
58,059
-4,598
-7% -$262K 0.04% 661
2023
Q1
$3.55M Sell
62,657
-953
-1% -$61.1K 0.04% 658
2022
Q4
$4.72M Buy
63,610
+1,693
+3% +$115K 0.06% 480
2022
Q3
$3.69M Sell
61,917
-4,378
-7% -$264K 0.05% 564
2022
Q2
$3.72M Sell
66,295
-5,771
-8% -$379K 0.05% 586
2022
Q1
$5.32M Buy
72,066
+1,386
+2% +$96.3K 0.06% 503
2021
Q4
$5.1M Buy
70,680
+1,658
+2% +$120K 0.05% 542
2021
Q3
$5.29M Buy
69,022
+610
+0.9% +$49K 0.05% 499
2021
Q2
$5.3M Sell
68,412
-1,217
-2% -$86.5K 0.05% 498
2021
Q1
$4.29M Sell
69,629
-57,347
-45% -$3.63M 0.05% 603
2020
Q4
$8.28M Sell
126,976
-1,176
-0.9% -$67.6K 0.09% 240
2020
Q3
$6.35M Sell
128,152
-8,993
-7% -$464K 0.08% 266
2020
Q2
$6.54M Sell
137,145
-6,383
-4% -$308K 0.09% 238
2020
Q1
$6.1M Sell
143,528
-1,805
-1% -$89.2K 0.1% 221
2019
Q4
$8.56M Buy
145,333
+1,237
+0.9% +$67.2K 0.11% 198
2019
Q3
$7.37M Buy
144,096
+340
+0.2% +$16.2K 0.1% 238
2019
Q2
$6.08M Buy
143,756
+297
+0.2% +$12.9K 0.09% 294
2019
Q1
$7.09M Buy
143,459
+10,983
+8% +$497K 0.1% 230
2018
Q4
$5.73M Buy
132,476
+6,479
+5% +$323K 0.09% 269
2018
Q3
$7.15M Buy
125,997
+63,059
+100% +$3.32M 0.1% 245
2018
Q2
$3.18M Buy
62,938
+3,386
+6% +$177K 0.05% 664
2018
Q1
$2.97M Buy
59,552
+660
+1% +$31K 0.05% 671
2017
Q4
$2.42M Buy
58,892
+2,134
+4% +$74.7K 0.04% 777
2017
Q3
$1.69M Sell
56,758
-817
-1% -$24.9K 0.03% 908
2017
Q2
$1.91M Buy
57,575
+2,396
+4% +$75.3K 0.03% 841
2017
Q1
$1.63M Sell
55,179
-2,229
-4% -$60.8K 0.03% 902
2016
Q4
$1.42M Buy
+57,408
New +$1.3M 0.03% 919
2015
Q2
Sell
-1,710
Closed -$43K 1252
2015
Q1
$43K Sell
1,710
-725
-30% -$17.7K ﹤0.01% 1195
2014
Q4
$58K Buy
2,435
+350
+17% +$7.75K ﹤0.01% 1154
2014
Q3
$41K Buy
2,085
+485
+30% +$9.98K ﹤0.01% 1198
2014
Q2
$38K Buy
+1,600
New +$38.6K ﹤0.01% 1224

Other funds holding GMED

Mutual of America Capital Management's GMED Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Globus Medical (GMED) stake by 1.5% in Q2 2026, selling an estimated $54.4K and leaving 42,054 shares worth $3.32M. The position accounts for 0.03% of the portfolio, ranked #589.

Mutual of America Capital Management first reported a position in GMED in Q2 2014 and has held it in 43 quarters since. The position peaked at $8.56M in Q4 2019. 369 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Mutual of America Capital Management held 42,054 shares of Globus Medical worth $3.32M as of Q2 2026.
  • Mutual of America Capital Management sold 640 Globus Medical shares in Q2 2026, an estimated $54.4K.
  • Globus Medical made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #589 holding.
  • Mutual of America Capital Management first reported a position in Globus Medical in Q2 2014 and has held it in 43 quarters since.
  • Mutual of America Capital Management's Globus Medical position peaked at $8.56M in Q4 2019.
  • 369 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.